Solaris Resources Inc. (CVE:SLS – Get Free Report) dropped 2.7% during trading on Monday . The stock traded as low as C$5.95 and last traded at C$6.15. Approximately 53,313 shares changed hands during mid-day trading, a decline of 60% from the average daily volume of 132,199 shares. The stock had previously closed at C$6.32.
Solaris Resources Stock Down 2.7 %
The company’s 50 day moving average is C$6.15 and its 200 day moving average is C$6.15.
About Solaris Resources
SELLAS Life Sciences Group, Inc, a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cancer.
Featured Stories
- Five stocks we like better than Solaris Resources
- What does consumer price index measure?
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Receive News & Ratings for Solaris Resources Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Solaris Resources and related companies with MarketBeat.com's FREE daily email newsletter.
